This bill would amend the Patent Act to make it easier to manufacture and export pharmaceutical products to developing countries. It seeks to eliminate some of the administrative constraints under Canada's Access to Medicine Regime.
This bill does not appear to be outside federal jurisdiction. It does not appear to violate the Constitution, including the Charter. It is not similar to a private member's bill already voted on in the current session. And it is not similar to a government bill already voted on in the current session.